[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"wellness\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:wellness":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,44,82,110,149,193,212,241],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100500932","neurocognitive-effects-of-non-invasive-near-infrared-light-stimulation-100500932",false,"NCT05802680","Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation","Inclusion Criteria:\n\n* 18 years of age or older\n\nExclusion Criteria:\n\n* None",true,"ALL","18 Years",{"count":19,"type":20},500,"ESTIMATED","INTERVENTIONAL",[23],"NA","Inattentiveness and impulsivity in healthy adults and individuals with attention deficit hyperactivity disorder (ADHD) diminish these individuals' quality of life. Cortical hypometabolism has been hypothesized to contribute to inattentiveness in ADHD. Transcranial photobiomodulation (tPBM) is a safe and non-invasive modality for activation of the prefrontal cortex. tPBM in healthy adults has been shown to augment brain oxygenation, cognition, and mood. The cognition-enhancing effect of tPBM on sustained attention in adults with ADHD remains unstudied. The investigators will evaluate whether tPBM administration to adults with and without ADHD can improve their attention. Each participant will be screened for eighteen criteria based on the Diagnostic and Statistical Manual (DSM-IV, text revised), using the validated instrument Adult ADHD Self-Report Scale (ASRS-v1.1). Blinded participants will be randomized into (I) Active-tPBM or (II) Sham-tPBM groups. After undergoing an 8-minute administration of Sham or 1064 nm tPBM to the lateral and medial right prefrontal cortex, each participant will complete a 14-minute, computer-based Conner's continuous performance task-3 (CPT-3). The investigators will examine whether adults with and without ADHD who receive Active-tPBM improve in measures of inattention, impulsivity, sustained attention, or vigilance compared to the Sham-tPBM group. Cognitive assessments of attention like the CPT-3 may evaluate the efficacy of tPBM to increase cortical metabolism in healthy adults and individuals with conditions like ADHD. The investigators anticipate their investigation will be a starting point for more sophisticated studies that focus on the implications of tPBM on cognition.",[26,27,28,29,30],"Attention Deficit Hyperactivity Disorder","Attention Difficulties","Attention Deficit","Cognitive Deficit","Wellness","RECRUITING","2026-06-17",{"date":34,"type":35},"2026-06-22","ACTUAL",{"date":37,"type":35},"2022-02-09",{"date":39,"type":20},"2027-02-01",{"name":41,"class":42},"Francisco Gonzalez-Lima, PhD","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":60,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":81},"100642803","a-study-of-a-mental-fitness-intervention-for-anesthesiology-resident-wellbeing-and-self-compassion-100642803","NCT07639827","A Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion","A Pilot Randomized Controlled Trial of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion","Inclusion Criteria:\n\n* Current PGY4 anesthesiology resident at Massachusetts General Hospital or Brigham and Women's Hospital\n* Willingness to provide informed consent\n\nResident Loved One Inclusion Criteria\n\n* The choice of a resident loved one will be at the discretion of the resident.\n* This may include partners, family, friends or other loved ones.\n* Only one individual per resident will be eligible to participate.\n* Residents will be eligible to participate even if no loved one is identified.\n\nExclusion Criteria:\n\n* Inability to complete English-language questionnaires\n* Inability to access and use the intervention components (smartphone app\u002Fweb platform)\n* Age \\\u003C18 years\n* Concurrent participation in another interventional study designed to target mental fitness or wellbeing",{"count":52,"type":20},60,[23],"The goal of this clinical trial is to learn if app-based wellness programs can help improve wellbeing and self-compassion for medical residents. This is a pilot study, which is done on a small group of people to learn if a larger study would be useful. The main questions it aims to answer are:\n\n1. Are app-based wellness interventions feasible and acceptable in a high-stress population like medical residents?\n2. Can app-based wellness programs improve wellbeing and self-compassion in medical residents?\n\nResearchers will compare the app-based wellness program to a time- and attention-matched control program.\n\nParticipants will:\n\n* Complete online questionnaires at the start of the study and again after completion of the wellness program\n* Be assigned by chance (like a coin toss) to one of two different app-based programs, and will participate in the assigned program for 6 weeks. Both programs will involve weekly lessons and brief, daily exercises. Engagement with these exercises will not be mandatory but highly encouraged.",[30,56,57,58,59],"Self Compassion","Burnout","Anxiety","Depression",[61,62,63,64,65,66,67,68,69,70],"mental fitness","wellness","self compassion","burnout","app-based intervention","residents","graduate medical education","positive psychology","anxiety","depression","NOT_YET_RECRUITING","2026-06-13",{"date":74,"type":35},"2026-06-16",{"date":76,"type":20},"2026-08",{"date":78,"type":20},"2027-01",{"name":80,"class":42},"Massachusetts General Hospital",2,{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":4,"eligibilityCriteria":88,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":89,"enrollmentInfo":90,"targetDuration":4,"studyType":21,"phases":92,"briefSummary":93,"conditions":94,"keywords":96,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":43},"100501515","assessing-the-effectiveness-of-digital-wellness-modules-on-perceived-quality-of-life-100501515","NCT05810259","Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life","Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life Via a Randomized Control Trial","Inclusion Criteria:\n\n* Resides in United States\n\nExclusion Criteria:\n\n* Any individual who endorses any of the following criteria will be excluded from participation in this study:\n* Positive Health Screening Questions, as measured by the Health Screening Questionnaire (HSQ):\n\n  * Pain, discomfort or pressure in the chest, difficulty breathing or shortness of breath, dizziness, fainting, or blackout, blood pressure with systolic greater than 140 or diastolic greater than 90, diagnosed or treated for any heart disease, heart murmur, chest pain (angina), palpitations (irregular beat), or heart attack, heart surgery, angioplasty, or a pacemaker, valve replacement, or heart transplant, resting pulse greater than 100 beats per minute, any arthritis, back trouble, hip \u002Fknee\u002Fjoint \u002Fpain, or any other bone or joint condition, personal experience or doctor's advice of any other medical or physical reason that would prohibit the participant from doing light to moderate physical exercise, personal physician's recommendation against participating in light to moderate physical exercise because of asthma, diabetes, epilepsy or elevated cholesterol or a hernia.\n* Positive Psychiatric Disorders Screening Questions:\n\n  * Positive screen for depression, excluding suicide (PHQ-8) cutoff score \\> 6\n  * Positive screen for panic (SMPD) cutoff score \\> 2\n  * Positive screen for generalized anxiety (GAD-7) cutoff score \\> 10\n  * Positive screen psychosis (PDSQ) via psychosis section, cutoff score \\> 3\n  * Positive screen mania via the Altman Self-Rating Mania Scale (ASRM) cutoff score \\> 6","65 Years",{"count":91,"type":20},120,[23],"The study will examine the role of digital wellness modules (brief mindfulness and light to moderate physical exercise) delivered through a smartphone wellness application and their short-term effects on health behavior motivation and change, and longer-term quality of life and non-pathological affective states.",[30,95,58,59],"Quality of Life",[97,62,98,99,100],"digital wellness interventions","mental health","mindfulness","exercise","2026-05-27",{"date":103,"type":35},"2026-05-29",{"date":105,"type":35},"2024-05-22",{"date":107,"type":20},"2027-03",{"name":109,"class":42},"Yale University",{"id":111,"slug":112,"hasResults":11,"nctId":113,"briefTitle":114,"officialTitle":114,"acronym":4,"eligibilityCriteria":115,"healthyVolunteers":15,"sex":16,"minAge":116,"maxAge":117,"enrollmentInfo":118,"targetDuration":4,"studyType":21,"phases":120,"briefSummary":121,"conditions":122,"keywords":124,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":140,"lastUpdatePostDateStruct":141,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":146,"locationsCount":43},"100636297","an-open-label-direct-to-consumer-study-assessing-the-impact-of-health-and-wellness-products-on-gi-health-and-related-health-outcomes-100636297","NCT07563855","An Open Label Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes","Inclusion Criteria:\n\n* Adults, at least 21-75 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities.\n* Assigned sex at birth will determine sex-specific recruitment and surveys (male vs female) employed, when needed\n* Resides in the United States\n* Has the opportunity for at least 30% improvement in their primary health outcome\n* One of the following:\n* Currently taking a GLP-1 for at least 3 months with no plans to stop or switch current GLP-1\n* Expressing the interest to lose weight, but not currently taking a GLP-1 in the last 6 months and with no plans to start taking a GLP-1\n* Must be willing to complete a biomarker collection (stool and blood) at 2 timepoints during the study (baseline and end of study)\n* Expresses a willingness to take the study product everyday for 4 weeks\n\nExclusion Criteria:\n\n* Report being pregnant, trying to become pregnant, or breastfeeding\n* Unable to provide a valid US shipping address and mobile phone number\n* Reports current enrollment in another clinical trial\n* Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)\n* Unable to read and understand English at a 7th grade level\n* Reports enrollment, current or within in the past 30 days, in another clinical trial\n* Reports a current and\u002For recent (up to 3 months ago) major illness and\u002For surgery that poses a known, significant safety risk.\n* Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and\u002For a significant safety risk with any of the study product ingredients.\n* NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure\n* Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.\n* Anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, medications that warn against grapefruit consumption, corticosteroids at doses greater than 5 mg per day, Diabetic medications to treat Type 1 or Type 2 diabetes , oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, MAOIs, or thyroid products\n* Reports current use, or use within the past 30 days, of whey protein and\u002For similar product(s) to the study product that may limit the effects of the study products and\u002For pose a safety risk\n* Reports taking an antibiotic or probiotic in the last 4 weeks\n* Lack of reliable daily access to the internet","21 Years","75 Years",{"count":119,"type":20},133,[23],"The purpose of this study is to:\n\n1. Understand the participant experience using a health and wellness product and effects of the study product on GLP-1 users and those trying to lose weight\n2. Understand how participants may use and accept a health and wellness product\n3. Understand the side effects of a health and wellness product\n4. Evaluate the quality and effects of a health and wellness product on participant health through self-reported measures (electronic surveys) and biomarker collections.",[123,30,95],"Health",[125,126,127,128,129,130,131,132,133,134,135,136,137,138,139],"product","beverage","protein","fiber","electrolytes","hydration","satiety","digestion","gastrointestinal","constipation","belly pain","GLP-1","weight","attitudes","behaviors","2026-04-29",{"date":142,"type":35},"2026-05-04",{"date":144,"type":20},"2026-04",{"date":76,"type":20},{"name":147,"class":148},"PepsiCo Global R&D","INDUSTRY",{"id":150,"slug":151,"hasResults":11,"nctId":152,"briefTitle":153,"officialTitle":154,"acronym":4,"eligibilityCriteria":155,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":156,"targetDuration":158,"studyType":159,"phases":4,"briefSummary":160,"conditions":161,"keywords":173,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":184,"lastUpdatePostDateStruct":185,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":4},"100630769","development-and-multicenter-validation-of-an-ai-based-remote-photoplethysmography-rppg-facial-scan-for-multimodal-health-assessment-100630769","NCT07491978","Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment","Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment: Agreement With Clinical, Laboratory, and Psychological Parameters in an Urban Population","Inclusion Criteria:\n\n1. Adults aged ≥18 years.\n2. Able and willing to provide written informed consent.\n3. Able to comply with study procedures, including face scan, physical examination, blood sampling, and questionnaire completion.\n4. Clinically stable at the time of assessment.\n\nExclusion Criteria:\n\n1. Facial conditions affecting the region of interest (ROI), such as injury, deformity, or impaired circulation, that may interfere with rPPG signal acquisition.\n2. Presence of facial tattoos or coverings that obstruct optical signal detection.\n3. Inability to remain still or comply with measurement procedures during data acquisition.\n4. Severe medical conditions that preclude safe participation, as judged by the investigator.\n5. Incomplete data or withdrawal of consent during the study.\n\n   \\-",{"count":157,"type":20},1000,"1 Day","OBSERVATIONAL","The goal of this observational study is to learn if a non-contact facial scan using artificial intelligence (AI) can be used to check health status in adults living in urban areas such as Jakarta. The facial scan uses a method called remote photoplethysmography (rPPG), which measures small changes in blood flow from the face using a camera.\n\nThe main questions this study aims to answer are:\n\n1. How close are the results from the facial scan to standard medical measurements, such as heart rate, breathing rate, blood pressure, and oxygen levels?\n2. Can the facial scan estimate other health indicators, such as blood sugar, lipid profile, HbA1c, and hemoglobin levels?\n3. Is there a relationship between the facial scan results and mental health, such as stress, anxiety, and depression?\n\nParticipants will take part in several simple and mostly non-invasive procedures:\n\n1. Answer questionnaires about their mental health and daily habits\n2. Have basic health checks, such as blood pressure, heart rate, and body measurements\n3. Provide a blood sample for laboratory testing\n4. Complete a facial scan using a camera for about 1 to 3 minutes\n\nResearchers will compare the results from the facial scan with standard clinical and laboratory tests to see how well the technology works.\n\nThis study may help develop a simple and accessible screening tool that can be used for early detection of health risks. It may also support the use of digital health and telemedicine in community and clinical settings.",[162,163,164,165,166,167,58,168,169,170,171,172,30],"Metabolic Syndrome","Hypertension","Diabetes (DM)","Tachycardia","ASCVD","Depression Disorder","Stress (Psychology)","Obesity & Overweight","Cardiometabolic Risk Factors","Cardiometabolic Health Indicators","Sleep",[174,175,176,177,178,179,180,181,182,183],"remote photoplethysmography","rPPG","artificial intelligence","digital biomarker","telemedicine","vital signs","cardiometabolic risk","machine learning","facial scan","screening tool","2026-04-15",{"date":186,"type":35},"2026-04-20",{"date":188,"type":20},"2026-04-24",{"date":190,"type":20},"2027-03-30",{"name":192,"class":42},"Tarumanagara University",{"id":194,"slug":195,"hasResults":11,"nctId":196,"briefTitle":197,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":15,"sex":16,"minAge":116,"maxAge":4,"enrollmentInfo":199,"targetDuration":4,"studyType":21,"phases":200,"briefSummary":201,"conditions":202,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":203,"lastUpdatePostDateStruct":204,"startDateStruct":206,"completionDateStruct":208,"leadSponsor":210,"locationsCount":4},"100563312","effectiveness-of-chilipad-in-enhancing-sleep-quality-ampamp-wellbeing-100563312","NCT06614530","Effectiveness of Chilipad in Enhancing Sleep Quality & Wellbeing","Inclusion Criteria:\n\n* in the United States\n* recent purchaser or customer of Sleep.me\n\nExclusion Criteria:\n\n* Individuals with severe insomnia\n* Individuals with severe allergies or skin conditions\n* Individuals with pacemakers or implanted medical devices\n* Individuals with severe anxiety or stress disorders\n* Pregnant individuals\n* Individuals who travel across timezones frequently and\u002For sleep in their own bed less than 21 days in a month.\n* Individuals with incontinence issues\n* Individuals with severe mobility issues.",{"count":91,"type":20},[23],"This study tests the Chilipad Dock Pro Bed Cooling System and Sleep Tracker, focusing on how temperature affects sleep quality and well-being. Over a 35-day period, metrics captured by our Sleep Tracker and participant feedback will be used to evaluate sleep quality and assess well-being. Participation requires minimal time and effort - set-up, sleep, and check-in periodically to provide feedback.",[172,30],"2024-09-24",{"date":205,"type":35},"2024-09-26",{"date":207,"type":20},"2024-10-01",{"date":209,"type":20},"2025-10-01",{"name":211,"class":148},"Efforia, Inc",{"id":213,"slug":214,"hasResults":11,"nctId":215,"briefTitle":216,"officialTitle":217,"acronym":218,"eligibilityCriteria":219,"healthyVolunteers":15,"sex":16,"minAge":116,"maxAge":4,"enrollmentInfo":220,"targetDuration":4,"studyType":159,"phases":4,"briefSummary":222,"conditions":223,"keywords":226,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":233,"startDateStruct":235,"completionDateStruct":237,"leadSponsor":239,"locationsCount":43},"100555044","ergonomics-in-the-cardiac-catheterization-laboratory-100555044","NCT06506968","Ergonomics in the Cardiac Catheterization Laboratory","Quantifying Ergonomic Risk in the Cardiac Catheterization Laboratory: A Comparative Study With and Without a 'Lead-free' Radiation Protection System","ERGO-CATH","Inclusion Criteria:\n\n* Any member of the BWH cardiac catheterization laboratory who participates in procedures including:\n* faculty interventional cardiologists and trainees\n* general cardiology fellows\n* residents\n* physician assistants\n* nurses\n* circulating and monitoring technologists\n* Physically able and willing to wear the sensors required for data collection in the study\n\nExclusion Criteria:\n\n* Interventionalists not actively participating in the BWH Cardiac Catheterization Lab\n* Not able or willing to wear the necessary sensors",{"count":221,"type":20},30,"The goal of this observational study is to quantify ergonomic risk associated with traditional protective equipment in operators working in the cardiac catheterization laboratory as compared with a mobile protection system. The main questions it aims to answer is:\n\nWhat is the mean time spent by operators in positions of high ergonomic postural risk during cases?\n\nParticipants will wear IMU, EMG, and radiation sensors, as well as complete baseline and discomfort surveys for several catheterization procedures.",[224,225,30],"Ergonomics","Orthopedic Injury",[227,228,229,230,231],"Catheterization Laboratory","PCI","CTO","TAVR","Coronary Angiography","2024-07-16",{"date":234,"type":35},"2024-07-18",{"date":236,"type":35},"2024-05-13",{"date":238,"type":20},"2024-12",{"name":240,"class":42},"Brigham and Women's Hospital",{"id":242,"slug":243,"hasResults":11,"nctId":244,"briefTitle":245,"officialTitle":245,"acronym":4,"eligibilityCriteria":246,"healthyVolunteers":15,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":247,"targetDuration":4,"studyType":159,"phases":4,"briefSummary":249,"conditions":250,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":252,"lastUpdatePostDateStruct":253,"startDateStruct":255,"completionDateStruct":257,"leadSponsor":259,"locationsCount":43},"100545386","collection-and-analyses-of-physiological-physical-and-molecular-data-from-a-diverse-population-100545386","NCT06381232","Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population","Inclusion Criteria:\n\n* Anyone that resides in the US at the time of enrollment.\n\nExclusion Criteria:\n\n* None",{"count":248,"type":20},20000,"The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.",[251,30],"General Health","2024-04-18",{"date":254,"type":35},"2024-04-24",{"date":256,"type":35},"2018-07-23",{"date":258,"type":20},"2028-07-23",{"name":260,"class":148},"Viome"]